xaloptic silmatilgad, lahus
medana pharma s.a. - latanoprost - silmatilgad, lahus - 50mcg 1ml 2.5ml 3tk; 50mcg 1ml 2.5ml 1tk
unilat silmatilgad, lahus
unimed pharma spol. s r.o. - latanoprost - silmatilgad, lahus - 50mcg 1ml 2.5ml 1tk
latanoprost-ratiopharm silmatilgad, lahus
ratiopharm gmbh - latanoprost - silmatilgad, lahus - 50mcg 1ml 2.5ml 1tk; 50mcg 1ml 2.5ml 6tk
vizilatan silmatilgad, lahus
bausch + lomb ireland limited - latanoprost - silmatilgad, lahus - 50mcg 1ml 2.5ml 1tk; 50mcg 1ml 2.5ml 3tk
xolair
novartis europharm limited - omalizumab - asthma; urticaria - ravimid hingamisteede obstruktiivsete haiguste, - allergiline asthmaxolair on näidustatud täiskasvanud, noorukid ja lapsed (6 kuni.
latanoprost cipla silmatilgad, lahus
cipla europe nv - latanoprost - silmatilgad, lahus - 50mcg 1ml 2.5ml 1tk
sudafed xylospray dex ninasprei, lahus
mcneil healthcare (ireland) limited - ksülometasoliin+dekspantenool - ninasprei, lahus - 1mg+50mg 1ml 10ml 1tk
cevenfacta
laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorraagilised ained - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.
latanoprost elvim silmatilgad, lahus
sia elvim - latanoprost - silmatilgad, lahus - 50mcg 1ml 2.5ml 1tk
mycophenolate mofetil sandoz 500mg õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - mükofenoolhape - õhukese polümeerikattega tablett - 500mg 120tk; 500mg 250tk; 500mg 180tk; 500mg 50tk; 500mg 150tk; 500mg 100tk